Publications by authors named "Gelsomina Aruta"

Glioblastoma (GBM) is the most common and aggressive central nervous system tumor, requiring multimodal management. Due to its malignant behavior and infiltrative growth pattern, GBM is one of the most difficult tumors to treat and gross total resection is still considered to be the first crucial step. The deep understanding of GBM microenvironment and the possibility of manipulating the patient's innate and adaptive immune system to fight the neoplasm represent the base of immunotherapeutic strategies that currently express the future for the fight against GBM.

View Article and Find Full Text PDF

Background: Peripheral nerve injuries (PNIs) include several conditions in which one or more peripheral nerves are damaged. Trauma is one of the most common causes of PNIs and young people are particularly affected. They have a significant impact on patients' quality of life and on the healthcare system, while timing and type of surgical treatment are of the utmost importance to guarantee the most favorable functional recovery.

View Article and Find Full Text PDF

Introduction: The association between multisutural craniosynostosis with Chiari malformation (CM), venous hypertension, and hydrocephalus is widely described in the literature, especially in children with paediatric craniofacial syndromes. Some efforts have been done in the last years to understand the complex pathogenetic mechanisms underlying this association, and several theories have been proposed. In particular, it is now accepted that the hypothesis of the overcrowding of the posterior fossa due to precocious suture fusion is the cause of the cerebellar herniation in syndromic and non-syndromic patients, against the theory of intrinsic cerebellar anomalies, ventriculomegaly, and venous hypertension.

View Article and Find Full Text PDF
Article Synopsis
  • CCMs can be categorized into sporadic (sCCM) or familial (fCCM), with fCCMs being linked to specific genetic mutations while sCCMs often associate with developmental venous anomalies (DVA) and have distinct pathological origins.
  • A 3-year-old patient underwent successful removal of a hemorrhagic sCCM in the brain, with follow-ups showing no immediate relapse, but 18 years later, a new hemorrhagic lesion appeared in the same area, necessitating further surgery.
  • The case suggests long-term recurrence of sCCMs can occur in connection with DVAs, potentially due to chronic inflammation caused by the DVA.
View Article and Find Full Text PDF
Article Synopsis
  • Glioblastoma patients currently have an average survival rate of only 15 months, prompting a focus on molecular biomarkers for improved diagnosis and treatment.
  • Recent research highlights the significant influence of non-cancerous cells in the tumor microenvironment on glioma growth and recurrence.
  • Advances in understanding interactions between glioma cells and immune cells may lead to new therapeutic strategies, but effective treatments will likely require targeting multiple molecular pathways simultaneously.
View Article and Find Full Text PDF